Aethlon Medical (AEMD) Stock Price, Quote & News

Company Profile

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Industry: Medical Devices

Sector: Healthcare

Phone: 619 941 0360

Fax: 619 941 0361

Website: www.aethlonmedical.com

Address:

11555 Sorrento Valley Road, Suite 203, San Diego, United States

Whales22 Oct. 24 at 8:38 PM

How much volume do you think it takes to gap CMCT up? CMCT has not even 700K shares float and recent news. Hoping for a 100% run on CMCT $AEMD $PSIG $LPSN $MOVE Watchlist,

0 · Reply

smoothest06 Oct. 24 at 3:40 PM

$AEMD

0 · Reply

_Sensei_ Oct. 24 at 2:32 PM

$AEMD

0 · Reply

Benalish Oct. 24 at 2:38 AM

$AEMD they will announce compliance soon and it will run

0 · Reply

Whales22 Oct. 23 at 7:47 AM

How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $AEMD $PSIG $LPSN $LGCL Watchlist

0 · Reply

Maxim_Trader Oct. 21 at 8:49 PM

$BYND Damg this is strong 💪🏽 $GME 2.0 Keep $AEMD on watch for a winner tooo

0 · Reply

Maxim_Trader Oct. 21 at 8:46 PM

$AEMD looking for $9 but with strong news 🗞️ Recent RS $15-$20 $CETX $NITO $CLIK all recent RSes but the Bios and Therapeutic tickers always run the hardest it seems.

0 · Reply

Maxim_Trader Oct. 21 at 8:25 PM

$AEMD $WOK AEMD will go too 💪🏽

0 · Reply

Alchemy_Trader Oct. 21 at 8:22 PM

$WOK easy $$. Need $AEMD to blast off as well. Low float, recent RS, low available, and high CTB.

0 · Reply

ZacksSCR Oct. 21 at 1:50 PM

$AEMD: Early Oncology Trial Data Looks Promising https://buff.ly/MItHtJF

0 · Reply

Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial

Sep 4, 2025, 9:15 AM EDT - 7 weeks ago

Aethlon Medical Announces Pricing of $4.5 Million Public Offering

Sep 3, 2025, 8:01 AM EDT - 7 weeks ago

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

Aug 13, 2025, 8:01 PM EDT - 2 months ago

Aethlon Medical, Inc. (AEMD) Q1 2026 Earnings Call Transcript

Aug 13, 2025, 4:15 PM EDT - 2 months ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update

Aug 5, 2025, 8:01 AM EDT - 2 months ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025

Jul 15, 2025, 8:01 AM EDT - 3 months ago

Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

Jun 26, 2025, 7:35 PM EDT - 4 months ago

Aethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call Transcript

Jun 26, 2025, 4:15 PM EDT - 4 months ago

Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

Jun 20, 2025, 8:01 AM EDT - 4 months ago

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

Jun 18, 2025, 8:01 AM EDT - 4 months ago

Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial

Jun 9, 2025, 8:01 AM EDT - 4 months ago

Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes

May 14, 2025, 8:01 AM EDT - 5 months ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

Mar 10, 2025, 8:01 AM EDT - 8 months ago

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Feb 13, 2025, 8:01 AM EST - 9 months ago

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Feb 12, 2025, 8:11 PM EST - 9 months ago

Aethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call Transcript

Feb 12, 2025, 4:15 PM EST - 9 months ago

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Feb 5, 2025, 8:01 AM EST - 9 months ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Jan 29, 2025, 8:01 AM EST - 9 months ago

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Dec 20, 2024, 8:01 AM EST - 11 months ago

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Nov 14, 2024, 8:00 AM EST - 1 year ago

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Nov 13, 2024, 7:58 PM EST - 1 year ago

Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript

Nov 13, 2024, 4:15 PM EST - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Nov 12, 2024, 8:00 AM EST - 1 year ago

Innovative Medical Technology Advances with First Patient Enrollments

Nov 11, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Nov 6, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Oct 8, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Sep 19, 2024, 8:01 AM EDT - 1 year ago

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Sep 17, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Present at Virtual Investor Conferences in September

Sep 17, 2024, 7:30 AM EDT - 1 year ago

Innovation Driving Cancer's Solid Tumors Market

Sep 16, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Sep 13, 2024, 8:35 AM EDT - 1 year ago

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Aug 27, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aug 14, 2024, 6:45 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q1 2025 Earnings Call Transcript

Aug 14, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

Aug 12, 2024, 9:01 AM EDT - 1 year ago

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aug 12, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aug 6, 2024, 9:12 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Jun 27, 2024, 6:37 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript

Jun 27, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Jun 21, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Jun 20, 2024, 7:00 AM EDT - 1 year ago

What's Next in Treatments for Cancer Patients with Solid Tumors?

Jun 18, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

Jun 7, 2024, 8:00 AM EDT - 1 year ago

The Hunt for Virus Treatments Continues Post Covid-19

Jun 3, 2024, 9:05 AM EDT - 1 year ago

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Jun 3, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

May 15, 2024, 9:15 AM EDT - 1 year ago

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

May 10, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Feb 21, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Whales22 Oct. 24 at 8:38 PM

How much volume do you think it takes to gap CMCT up? CMCT has not even 700K shares float and recent news. Hoping for a 100% run on CMCT $AEMD $PSIG $LPSN $MOVE Watchlist,

0 · Reply

smoothest06 Oct. 24 at 3:40 PM

$AEMD

0 · Reply

_Sensei_ Oct. 24 at 2:32 PM

$AEMD

0 · Reply

Benalish Oct. 24 at 2:38 AM

$AEMD they will announce compliance soon and it will run

0 · Reply

Whales22 Oct. 23 at 7:47 AM

How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $AEMD $PSIG $LPSN $LGCL Watchlist

0 · Reply

Maxim_Trader Oct. 21 at 8:49 PM

$BYND Damg this is strong 💪🏽 $GME 2.0 Keep $AEMD on watch for a winner tooo

0 · Reply

Maxim_Trader Oct. 21 at 8:46 PM

$AEMD looking for $9 but with strong news 🗞️ Recent RS $15-$20 $CETX $NITO $CLIK all recent RSes but the Bios and Therapeutic tickers always run the hardest it seems.

0 · Reply

Maxim_Trader Oct. 21 at 8:25 PM

$AEMD $WOK AEMD will go too 💪🏽

0 · Reply

Alchemy_Trader Oct. 21 at 8:22 PM

$WOK easy $$. Need $AEMD to blast off as well. Low float, recent RS, low available, and high CTB.

0 · Reply

ZacksSCR Oct. 21 at 1:50 PM

$AEMD: Early Oncology Trial Data Looks Promising https://buff.ly/MItHtJF

0 · Reply

2TrustHim Oct. 21 at 12:44 PM

$AEMD Who Thinks Huge News Coming???!!

0 · Reply

2TrustHim Oct. 21 at 12:42 PM

$AEMD DARK POOL READY!!!

0 · Reply

BallsOfPowder Oct. 20 at 9:40 PM

$AEMD WTF I lost all my 8 shares , was the reverse split without knowing, my broker can't even lent me 1 euro to buy me 2 so I had 10 for that 1 share , now I lost my full investment and never can have it back. What a fraud brokers are

0 · Reply

TwongStocks Oct. 20 at 8:26 PM

Today's reverse split results. All four closed green: $AEMD 1 for 10 Previous close $0.5432, $5.432 split-adjusted Intraday high $5.88 Today's close $5.51 🟢Up 1.44% $DHAI 1 for 25 Previous close $0.1247, $3.1175 split-adjusted Intraday high $3.7179 Today's close $3.54 🟢Up 13.55% $ETHZ 1 for 10 Previous close $1.68, $16.80 split-adjusted Intraday high $18.31 Today's close $17.12 🟢Up 1.90% $SENS 1 for 20. Previous close $0.408, $8.16 split-adjusted Premarket high $8.76 Today's close $8.47 🟢Up 3.80%

0 · Reply

inapick Oct. 20 at 3:17 PM

$AEMD seriously another reverse split so soon after the other, thats 3 x now for me and they have sucked me dry.

0 · Reply

UnicornPicks Oct. 20 at 1:49 PM

$GSIT $DHAI $AEMD $ABAT ideas this morning - one already +20% ROI!! Lets get it!

0 · Reply

TwongStocks Oct. 20 at 12:17 PM

$AEMD $DHAI $ETHZ $SENS All with reverse splits this morning. Trading will resume at 9:00am ET. RS details in the quoted post.

1 · Reply

FreeBeerTomorrow Oct. 18 at 9:29 AM

$AEMD ** Aethlon Medical, Inc. (AEMD) will effect a one-for-ten (1-10) reverse stock split of its Common Stock, with the reverse split becoming effective on Monday, October 20, 2025. Estimated Shares Outstanding After Split: $7,612,106 / 10 \approx 761,210 shares .

0 · Reply

TwongStocks Oct. 17 at 8:08 PM

I am aware of four reverse splits on Monday. Three on NASDAQ and one on NYSE American. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Monday morning. NASDAQ: $AEMD 1 for 10. Will reduce outstanding shares from approx 7.61m to approx 761k. Previously did a 1 for 8 RS in June 2025 that reduced the OS to approx 2.5m. OS increased by approx 5m after the June RS. $DHAI 1 for 25. Will reduce outstanding shares from approx 52.32m to approx 2.09m. $ETHZ 1 for 10. Will reduce outstanding shares from approx 160m to approx 16m. NYSE American: $SENS 1 for 20. Will reduce outstanding shares from approx 814.68m to approx 40.73m

1 · Reply

TwongStocks Oct. 16 at 7:09 PM

$AEMD NASDAQ Equity Corporate Actions Alert # 2025 - 567 Information Regarding the Reverse Stock Split and CUSIP Number Change for Aethlon Medical, Inc. (AEMD) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-567 Aethlon Medical, Inc. (AEMD) will effect a one-for-ten (1-10) reverse split of its Common Stock. The reverse stock split will become effective on Monday, October 20, 2025. In conjunction with the reverse split, the CUSIP number will change to 00808Y604.

0 · Reply

gifor Oct. 16 at 6:13 PM

$AEMD more dilution

0 · Reply

Bazzzigar Oct. 16 at 4:44 PM

$AEMD in

0 · Reply

Market Cap	1.36M
Revenue (ttm)	0.00
Net Income (ttm)	-13.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	56,000
Avg Vol	390,860
Day's Range	N/A - N/A
Shares Out	260,000.00
Stochastic %K	29%
Beta	1.82
Analysts	Hold
Price Target	$9.75